CN101129409B - Antimycotic externally used drug - Google Patents

Antimycotic externally used drug Download PDF

Info

Publication number
CN101129409B
CN101129409B CN2007100550552A CN200710055055A CN101129409B CN 101129409 B CN101129409 B CN 101129409B CN 2007100550552 A CN2007100550552 A CN 2007100550552A CN 200710055055 A CN200710055055 A CN 200710055055A CN 101129409 B CN101129409 B CN 101129409B
Authority
CN
China
Prior art keywords
tinea
antimycotic
medicine
effect
propolis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2007100550552A
Other languages
Chinese (zh)
Other versions
CN101129409A (en
Inventor
程贵昌
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN2007100550552A priority Critical patent/CN101129409B/en
Publication of CN101129409A publication Critical patent/CN101129409A/en
Application granted granted Critical
Publication of CN101129409B publication Critical patent/CN101129409B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention discloses an externally-used medicament for treating skin mycosis diseases, which is prepared from the raw materials of (by weight percent) terbinafine hydrochloride or miconazole or ketoconazole 0. 5-2%, Clobetasol Propionate 0. 01-0. 2%, neomycin sulphate 0. 3-1%, bee glue 5-25%, and balancing distilled water.

Description

A kind of antimycotic externally used drug
Technical field
The present invention relates to a kind of external preparation for skin medicine, relate in particular to the medicine for external use of treatment dermatomycosis.
Background technology
The dermatosis that fungal infection causes is a kind of relatively more obstinate, be difficult to the thoroughly disease of healing, common have a tinea capitis, tinea manus and pedis, tinea cruris, tinea corporis etc., often Pruritus unbearably, certain infectiousness is arranged, bring many inconvenience for people's live and work, the dermopathic topical agent of general treatment antimycotic has miconazole, ketoconazole, clotrimazole, salicylic acid, acetic acid etc., how based on pure Western medicine, the topical agent of Chinese medicine is less, and with regard to existing medicament, medicament takes effect slower mostly, skin there is certain zest, and cause the skin drug resistance easily, recurrence easily, the treatment dermatosis antimycotic externally used drug that Chinese medicine and western medicine combines does not appear in the newspapers at present.
Summary of the invention
Be directed to present antimycotic treatment external use medicine for treating dermatosis present situation, the object of the invention is, provides a kind of compatibility simple, reasonable, the Chinese and Western combination, and instant effect is difficult for recurrence, and the little medicine for external use of toxic and side effects.
For realizing the object of the invention, technical scheme is passed through following each component compatibility as effective ingredient, each component is by weight percentage: TER-HCL or miconazole or ketoconazole 0.5%--2%, clobetasol propionate 0.01-0.2%, polygynax 0.3-1%, propolis 5-25%, surplus is stayed water for steaming.
This medicament preparation method is as follows: liquid paraffin 6-10%, octadecanol 5-8%, monoglyceride 2% are made an amount of oil phase, add TER-HCL or ketoconazole or miconazole 0.5%--2%, clobetasol propionate 0.01-0.2% in 80 degree; With glycerol 5%, peregal 2%, propylene glycol 3%, that formicester 0.03% is made water is an amount of.In the 60-80 degree oil phase is added water, stir.Be cooled to the 50-60 degree and add 0.3-1% polygynax and stirring.Treat that temperature reduces to 40 degree and add propolis 5-25%, cross the ultrasonic emulsification machine, make this ointment agent, also can add medicinal spray substrate and make spray.
Innovation of the present invention is: existing anti-microbial type Western medicine has been carried out screening, combination, select existing anti-microbial type medicine for use: TER-HCL or miconazole or ketoconazole, clobetasol propionate, polygynax, and added natural antibacterial composition---propolis on this basis.
Anti-microbial type medicine TER-HCL or miconazole or ketoconazole have better therapeutic effect to tinea corporis, tinea cruris, the tinea manuum etc.; Polygynax has good killing effect to gram negative bacteria and gram positive bacteria; Clobetasol propionate can improve antibiotic property and antipruritic, antiallergic at this; And contain in the propolis trace aminoacid: valine, lysine, arginine, leucine, glutamic acid, different propylhomoserin, cysteine etc., most aminoacid are essential by human body, some or even human body can not be synthetic, in addition, also contain abundant mineral and trace element zinc, selenium, calcium etc. and vitamin B1, vitamin B2, vitamin B3, vitamin E etc. in the propolis, of paramount importance be propolis contain multiple organic acid such as: benzoic acid, ferulic acid, caffeic acid, benzoic acid have anticorrosion, phlegm-dispelling functions; Ferulic acid has antiinflammatory, analgesic effect; Caffeic acid has effects such as hemostasis.Natural and complexity based on the propolis composition, propolis has broad spectrum antibacterial function, 10 kinds of tinea bacterium there are stronger antibacterial, antibacterial action, malignant bacteria, virus, protozoon etc. are had suppress or killing action, for this reason, utilize the above-mentioned characteristic of propolis, be applied in the anti-microbial type medicament, be used in combination, to improve the antibiotic strength of antimicrobial drug with above-mentioned selected anti-microbial type medicine, prolong its antibacterial activity, strengthen the curative effect of anti-microbial type medicine.To treatment human body dermatitis and eczema, tinea corporis, tinea cruris, the tinea manuum, pruritus vulvae, beriberi etc. are had better therapeutic effect by the dermatosis of fungus/bacterial infection, play health-care effect preferably.
Compound preparation of the present invention can be made various dosage forms, for example solution, aerosol, ointment etc.Usage: put body surface fungal infection place outward on the skin, common dose: should clean before the medication and dry affected part every day 1-2 time, then medicament is applied to affected part and on every side, and gently be rubbed, if affected part intertrigo, available especially at night gauze applies lid after embrocating.The course of treatment: tinea corporis, 1~2 week of tinea cruris, 2~3 weeks of tinea pedis, tinea versicolor 1-3 week.
With its ointment is example, and the animal efficacy of medicine observing of this ointment anti-fungal infection of external is as follows:
Each 30 of Cavia porcelluss, male and female are not limit, and are divided into three groups, 10 every group.The back unhairing is used the sand paper scratch mark, inoculates the normal saline solution of Trichophyton mentagrophytes, makes the infection model of Trichophyton mentagrophytes, occurs erythema and edema after three days, implements administration.Give normal saline first group of every day, give hydrochloric acid Te Naifen second group of every day, spray with spray of the present invention the 3rd group of every day.Once a day, each consumption is that medicinal liquid evenly covers affected part.Administration is the 5th day and 10 days respectively, and the skin lesion of observing Cavia porcellus improves situation and fungus removing situation.The index that skin lesion obviously improves is no erythema, no edema.Fungus removing situation investigation method is that the tissue of getting infection site is cultivated, and observes whether conk is arranged, and is fungus as no conk and thoroughly removes.Observed result sees Table 1.
Table 1 preparation of the present invention is to the animal efficacy of medicine observing
Figure GSB00000361447700031
As shown in Table 1, medicament of the present invention infects the very obvious and short treating period of Cavia porcellus therapeutic effect to Trichophyton mentagrophytes.
Beneficial effect of the present invention is, use through tinea corporis, tinea cruris, tinea manus and pedis, tinea versicolor and seborrheic dermatitis of head patient, product behind the proof interpolation propolis is with respect to the product of pure western medicine composition, curative effect improves a lot, through 265 routine patient's usefulness, cure rate average 84%, effective percentage average 99%, and shorten the course of treatment, is difficult for recurrence, and because of adding propolis the regenerated effect of the histiocyte of promotion is arranged.
Promote the experiment of histiocyte regeneration, cause 4 place's skin injurys on the ear of rabbit, coat preparation of the present invention at two place's wound surface then, other two places are left intact, in contrast.Two place's epidermises that the result coats preparation of the present invention were just fully recovered at the 6th day, ulcer occurred without two place's wound surface of any processing, only saw that at the ulcer edge a small amount of epithelial cell growth is arranged, and did not see recovery from illness.Description of test, preparation of the present invention have the regenerated effect of the histiocyte of promotion.
This medicament clinical observation result such as following table:
Criterion of therapeutical effect: cure: use 1-3 after week continuously, skin lesion improves: disappearance is oozed out in erosion, desquamation disappears, and pruritus disappears.
Produce effects: use 1-3 after week continuously, skin lesion improves (erosion ooze out alleviate, desquamation reduces), and more than 60%, pruritus obviously alleviates.
Take a turn for the better: use 1-3 after week continuously, skin lesion improves (erosion ooze out alleviate, desquamation reduces), and more than the 60%-20%, pruritus alleviates.
Invalid: as to use 1-3 after week continuously, state of an illness no change.
The specific embodiment
For better illustrating as follows for embodiment to the present invention:
Embodiment
Get liquid paraffin 10g, octadecanol 5g, monoglyceride 2g makes an amount of oil phase, adds 1g TER-HCL or ketoconazole, clobetasol propionate 0.02g under 80 temperature; Get glycerol 5g, peregal 2g, propylene glycol 3g, formicester 0.03g make water.Under the 60-80 temperature, oil phase is added water, stir; Being cooled to 50-60 degree adding polygynax 0.3g then stirs.Add water-soluble bee glue 20g when spending when temperature is cooled to 40, cross ultrasonic emulsification machine-processed unguentum 100g.
Typical case's case history
Certain male people from Zhengzhou City, 45 years old, beriberi ulceration patient suffered from vitamin B1 deficiency for many years, uses Western medicine for many years, and recurrence often very is worried, uses this preparation, and the beriberi of showing effect repeatedly after 14 days is cured, the skin that the ulceration director makes new advances.
Certain male people from Kaifeng, 56 years old, the psoriatic suffered from psoriasis for many years, used existing Western medicine, and this preparation is used in outbreak repeatedly, and psoriasis is completely cured after 10 days, short treating period, effect is better, welcome by it.
Certain women people from Luoyang 40 years old, tinea manuum patient suffers from the tinea manuum for many years, uses existing Western medicine obstinate, uses this preparation, and the tinea manuum is cured after 7 days, does not have recurrence, short treating period, effect is better.
Certain women people from Luoyang 40 years old, the dermatitis and eczema patient suffers from dermatitis and eczema for many years, uses existing Western medicine obstinate, uses this preparation, and the tinea manuum is cured after 12 days, does not have recurrence, short treating period, effect is better.

Claims (1)

1. an antimycotic externally used drug is characterized in that, contains following component, each component by weight percentage: TER-HCL 0.5%-2%, clobetasol propionate 0.01-0.2%, polygynax 0.3-1%, propolis 5-25%, surplus is a distilled water.
CN2007100550552A 2007-08-30 2007-08-30 Antimycotic externally used drug Expired - Fee Related CN101129409B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2007100550552A CN101129409B (en) 2007-08-30 2007-08-30 Antimycotic externally used drug

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2007100550552A CN101129409B (en) 2007-08-30 2007-08-30 Antimycotic externally used drug

Publications (2)

Publication Number Publication Date
CN101129409A CN101129409A (en) 2008-02-27
CN101129409B true CN101129409B (en) 2011-06-01

Family

ID=39126919

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2007100550552A Expired - Fee Related CN101129409B (en) 2007-08-30 2007-08-30 Antimycotic externally used drug

Country Status (1)

Country Link
CN (1) CN101129409B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102697669A (en) * 2012-06-19 2012-10-03 广西博科药业有限公司 Compound ketoconazole liquid shampoo
CN103417557A (en) * 2013-08-14 2013-12-04 天津药业集团新郑股份有限公司 Compound ketoconazole cream
CN103432148B (en) * 2013-08-14 2016-03-02 遂成药业股份有限公司 A kind of preparation method of Compound Ketoconazole Cream
CN104288625B (en) * 2014-10-28 2017-09-12 河南中医学院 A kind of gingko external application paste for treating ringworm of the body
CN104825460A (en) * 2015-03-30 2015-08-12 上海中华药业南通有限公司 Dermatomycosis treatment emulsifiable paste and preparation method thereof
CN105560295A (en) * 2015-04-08 2016-05-11 王晓丽 Propolis composition capable of restraining fungi

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1097601A (en) * 1993-07-17 1995-01-25 李乐选 The medicine and the preparation technology thereof of treatment tinea pedis

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1097601A (en) * 1993-07-17 1995-01-25 李乐选 The medicine and the preparation technology thereof of treatment tinea pedis

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
郭业青.复方氯倍他索霜的制备及临床应用.天津药学14 3.2002,14(3),46-47.
郭业青.复方氯倍他索霜的制备及临床应用.天津药学14 3.2002,14(3),46-47. *

Also Published As

Publication number Publication date
CN101129409A (en) 2008-02-27

Similar Documents

Publication Publication Date Title
US7262180B2 (en) Compositions and methods for the treatment of inflammatory conditions of mucosae, skin and the eye
JP2011522831A (en) Acne treatment composition containing nanosilver and use thereof
CN101129409B (en) Antimycotic externally used drug
CN104622897A (en) Skin moisturizer for treating skin disease and preparation method of skin moisturizer
KR20050089740A (en) Topical formulation for treatment of rosacea
CN107670027B (en) Compositions and methods for treating skin conditions
AU2008203101A1 (en) Topical compositions comprising telmesteine for treating dermatological disorders
CN102861128B (en) Application of effective site of salvianolic acids to preparation of preparations for treating skin diseases
CN1985883B (en) Antifungal medicine composition and its preparing method and use
CN101259149A (en) Tinctura for treating beriberi
US20160058812A1 (en) Compositions for the treatment of peripheral ulcers of various origins
US10588979B1 (en) Cannabinoid and terpene-infused topical cream
JPH03255033A (en) Treating agent for trichophyton
CN106511478A (en) Compound essential oil for treating dog tinea as well as preparation method and applications of compound essential oil
Mishra et al. Topical antibiotics and semisolid dosage forms
CN108619486B (en) Ointment for treating skin diseases and preparation method thereof
CN106729673A (en) A kind of composition for the superficial surface of a wound
CN105920103A (en) External spray for treating dermatophytosis and preparation method thereof
CN1471916A (en) Medicnial composition containing biphenyl lambral for treating superficial mycosis
KR20090071529A (en) Cosmetic composition comprising vitamin k1 or vitamin k3 for anti-bacterial and anti-fungal bio-activity
CN107669744A (en) Pack containing industrial hemp
CN101940701A (en) Aloe oculentum and preparation method
CN105434431A (en) Multifunctional externally applied antibacterial preparation, and preparing method and application thereof
CN1268349C (en) Water soluble medicament for anti inflammation, repressing bacteria, eliminating pes off smell and treating asjike, and its application
CN100434080C (en) A medicine for treating dermatosis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20110601

Termination date: 20130830